CRP and Ito hypomelanosis: In a cohort of hospitalized patients with COPD (GOLD III–IV), a day-1 CRP level >1.29 mg/L was identified as the optimal diagnostic cutoff for COPD-associated IPA, with sensitivity 91.2% and specificity 57.7%.